Accuracy of combined multi-parametric MRI and PSMA PET-CT in diagnosing localized prostate cancer: newer horizons for a biopsy-free pathway
Abstract Introduction Prostate-specific antigen (PSA) is a reliable biomarker for identification of prostate cancer, although a biopsy is still the gold standard for detecting prostate cancer. Similar to higher PIRADS lesions on MRI, the maximal standard uptake value (SUV max) on PSMA PET is linked...
Main Authors: | Aditya Prakash Sharma, Rajender Kumar, Rohit Chauhan, Shiraz Akif Ziauddin, Shanky Singh, Harmandeep Singh, Sudheer Kumar Devana, Ujjwal Gorsi, Girdhar Singh Bora, Ravimohan S. Mavuduru, Santosh Kumar, Uttam K. Mete, Bhagwant Rai Mittal |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2023-11-01
|
Series: | European Journal of Hybrid Imaging |
Subjects: | |
Online Access: | https://doi.org/10.1186/s41824-023-00182-5 |
Similar Items
-
Application of targeted diagnosis of PSMA in the modality shift of prostate cancer diagnosis: a review
by: Li Yan, et al.
Published: (2023-09-01) -
Negative biopsy histology in men with PI-RADS score 5: is it useful PSMA PET/CT evaluation?
by: Pietro Pepe, et al.
Published: (2024-06-01) -
Targeted prostate biopsy: 68Ga-PSMA PET/CT vs. mpMRI in the diagnosis of prostate cancer
by: Pietro Pepe, et al.
Published: (2022-09-01) -
Comparison of 68Ga-PSMA PET and mpMRI for prostate cancer local staging: a comprehensive review and direct meta-analysis
by: Xinyu Jin, et al.
Published: (2024-11-01) -
68Ga-PSMA-11 PET/MRI versus multiparametric MRI in men referred for prostate biopsy: primary tumour localization and interreader agreement
by: Daniela A. Ferraro, et al.
Published: (2022-07-01)